Salmonella enterica induces joint inflammation and expression of interleukin-17 in draining lymph nodes early after onset of enterocolitis in mice

Infection and Immunity

Volumn 80, Issue 6, 2012, Pages 2231-2239

  Llana, Mariángeles Noto ^a   Sarnacki, Sebastián Hernán ^a   Vázquez, María Victoria ^a   Gartner, Alejandra Sonia ^a   Giacomodonato, Mónica Nancy ^a   Cerquetti, María Cristina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; STREPTOMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; ENTEROCOLITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INGUINAL LYMPH NODE; INOCULATION; LYMPH NODE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTIVE ARTHRITIS; SALMONELLA ENTERITIDIS; SALMONELLOSIS; SYNOVITIS; TYPE III SECRETION SYSTEM; ANIMAL; ANIMAL SALMONELLOSIS; BAGG ALBINO MOUSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFECTIOUS ARTHRITIS; INTESTINE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SALMONELLA ENTERICA;

ANIMALS; ARTHRITIS, INFECTIOUS; ENTEROCOLITIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; INTERLEUKIN-17; INTESTINES; LYMPH NODES; MICE; MICE, INBRED BALB C; SALMONELLA ENTERICA; SALMONELLA INFECTIONS, ANIMAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863852578     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/iai.00324-12     Document Type: Article

References (67)

1. Braun J, et al. 1999. Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis. Arthritis Rheum. 42, 2039-2044
2. Breban M, et al. 1996. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J. Immunol. 156, 794-803
3. Brewerton DA, et al. 1973. Ankylosing spondylitis and HL-A 27. Lancet i, 904-907
4. Bush KA, Walker JS, Lee CS, Kirkham BW. 2001. Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis, interleukin-17 expression is upregulated in early disease. Clin. Exp. Immunol. 123, 487-495
5. Butrimiene I, et al. 2004. Different cytokine profiles in patients with chronic and acute reactive arthritis. Rheumatology 10, 1300-1304
6. Cepek KL, et al. 1994. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 372, 190-193
7. Chabaud M, et al. 1999. Human interleukin-17, a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42, 963-970
8. dos Santos LR, et al. 2001. Polymerase chain reaction (PCR) for the detection of Salmonella in artificially inoculated chicken meat. Rev. Inst. Med. Trop. Sao Paulo 5, 247-250
9. Egan PJ, van Nieuwenhuijze A, Campbell IK, Wicks IP. 2008. Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis. Arthritis Rheum. 58, 3720-3729
10. Elewaut D, et al. 1998. Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis. J. Rheumatol. 25, 1932-1937
11. Fantini MC, Pallone F, Monteleone G. 2009. Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies. World J. Gastroenterol. 15, 2472-2478
12. Ferraccioli G, Zizzo G. 2011. The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation, rheumatoid arthritis as a model. Discov. Med. 60, 413-424
13. Fossiez F, et al. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 6, 2593-2603
14. Geddes K, et al. 2011. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat. Med. 17, 837-844
15. Giacomodonato MN, et al. 2009. Impaired synthesis and secretion of SopA in Salmonella Typhimurium dam mutants. FEMS Microbiol. Lett. 1, 71-77
16. Glatigny S, et al. 2012. Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats. Arthritis Rheum. 1, 110-120
17. Godinez I, et al. 2009. Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine. Infect. Immun. 77, 387-398
18. Granfors K, et al. 1990. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 335, 685-688
19. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. 1990. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m, an animal model of HLA-B27-associated human disorders. Cell 63, 1099-1112
20. Hapfelmeier S, Hardt WD. 2005. A mouse model for S. Typhimuriuminduced enterocolitis. Trends Microbiol. 13, 497-503
21. Hendriksen RS, et al. 2011. Global monitoring of Salmonella serovar distribution from the World Health Organization Global Foodborne Infections Network Country Data Bank, results of quality assured laboratories from 2001 to 2007. Foodborne Pathog. Dis. 8, 887-900
22. Hickman-Brecks CL, Racz JL, Meyer DM, LaBranche TP, Allen PM. 2011. Th17 cells can provide B cell help in autoantibody induced arthritis. J. Autoimmun. 36, 65-75
23. Hovsepian E, Penas F, Goren NB. 2010. 15-Deoxy-Δ prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, Nos-2, and ciclooxygenase 2 expression and functions by peroxisome proliferators-activated receptor γ-dependent and independent mechanisms in cardiac cells. Shock 34, 60-67
24. Inman RD, Johnston ME, Hodge M, Falk J, Helewa A. 1988. Postdysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of salmonellosis. Arthritis Rheum. 31, 1377e-1383e
25. Ivanov II, et al. 2006. The orphan nuclear receptor RORγ t directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133.
26. Jacques P, Mielants H, Coppieters K, De Vos M, Elewaut D. 2007. The intimate relationship between gut and joint in spondyloarthropathies. Curr. Opin. Rheumatol. 19, 353-357
27. Jacques P, Elewaut D. 2008. Joint expedition, linking gut inflammation to arthritis. Mucosal Immunol. 1, 364-371
28. Jacques P, Elewaut D, Mielants H. 2010. Interactions between gut inflammation and arthritis/spondylitis. Curr. Opin. Rheumatol. 4, 368-374
29. Jandus C, et al. 2008. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum. 58, 2307-2317
30. Kehlen A, Thiele K, Riemann D, Langner J. 2002. Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin. Exp. Immunol. 3, 539-546
31. Koenders MI, et al. 2005. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am. J. Pathol. 167, 141-149
32. Koenders MI, et al. 2011. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis, rationale for combination treatment during arthritis. Arthritis Rheum. 8, 2329-2339
33. Kontny E, et al. 2012. Comparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli, contribution to adipocytokine network. Ann. Rheum. Dis. 2, 262-267
34. Kotake S, et al. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103, 1345-1352
35. Kum WW, Lo BC, Yu HB, Finlay BB. 2011. Protective role of Akt2 in Salmonella enterica serovar Typhimurium-induced gastroenterocolitis. Infect. Immun. 7, 2554-2566
36. Lahesmaa R, et al. 1992. Yersinia enterocolitica activates a T helper type 1-like T cell subset in reactive arthritis. J. Immunol. 148, 3079-3085
37. Linam WM, Gerber MA. 2007. Changing epidemiology and prevention of Salmonella infections. Pediatr. Infect. Dis. J. 8, 747-748.
38. Mayuzumi H, Inagaki-Ohara K, Uyttenhove C, Okamoto Y, Matsuzaki G. 2010. Interleukin-17A is required to suppress invasion of Salmonella enterica serovar Typhimurium to enteric mucosa. Immunology 131, 377-385
39. Meyer A, et al. 2011. Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis. Arthritis Rheum. 5, 1274-1280
40. Meyer-Bahlburg A, et al. 2004. Yersinia enterocolitica leads to transient induction of TNF-alpha and activates NF-kappaB in synovial fibroblasts. Clin. Exp. Rheumatol. 22, 278-284
41. Nakae S, et al. 2003. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. U. S. A. 100, 5986-5990
42. Neubould BB. 1964. Role of lymph nodes in adjuvant-induced arthritis in rats. Ann. Rheum. Dis. 23, 392-396
43. Noto Llana M, et al. 2009. Sublethal infection with Salmonella Enteritidis by the natural route induces intestinal and joint inflammation in mice. Microbes Infect. 11, 74-82
44. Palm O, Moum B, Ongre A, Gran JT. 2002. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease, a population study (the IBSEN study). J. Rheumatol. 29, 511-515
45. Park H, et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 11, 1133-1141
46. Purrmann J, et al. 1988. HLA antigens in ankylosing spondylitis associated with Crohn's disease. Increased frequency of the HLA phenotype B27,B44. J. Rheumatol. 15, 1658-1661
47. Rohekar S, et al. 2008. Symptomatic acute reactive arthritis after an outbreak of Salmonella. J. Rheumatol. 35, 1599-1602
48. Schlaak J, et al. 1992. Predominance of Th1-type T cells in synovial fluid of patients with Yersinia-induced reactive arthritis. Eur. J. Immunol. 22, 2771-2776
49. Shin EW, et al. 1999. A case of Salmonella-triggered reactive arthritis in a child, initially presented as juvenile rheumatoid arthritis. Pediatr. Allergy Respir. Dis. 9, 320-326
50. Simon AK, et al. 1993. Analysis of cytokine profiles in synovial T cell clones from chlamydial reactive arthritis patients, predominance of the Th1 subset. Clin. Exp. Immunol. 94, 122-126
51. Singh AK, Misra R, Aggarwal A. 2011. Th-17 associated cytokines in patients with reactive arthritis/undifferentiated spondyloarthropathy. Clin. Rheumatol. 6, 771-776
52. Singh R, Aggarwal A, Misra R. 2007. Th1/Th17 cytokine profiles in patients with reactive arthritis/ undifferentiated spondyloarthropathy. J. Rheumatol. 34, 2285-2290
53. Sinha R, Aggarwal A, Prasad K, Misra R. 2003. Sporadic enteric reactive arthritis and undifferentiated spondyloarthropathy, evidence for involvement of Salmonella typhimurium. J. Rheumatol. 30, 105-113
54. Steer S, et al. 2003. Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn's disease. J. Rheumatol. 30, 518-522
55. Steiner G, et al. 1999. Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology 3, 202-213
56. Straub RH, Paimela L, Peltomaa R, Schölmerich J, Leirisalo-Repo M. 2002. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum. 3, 654-662
57. Toh ML, et al. 2010. Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression. PLoS One 10, e13416
58. Trentham DE, Townes AS, Kang AH. 1977. Autoimmunity to type II collagen an experimental model of arthritis. J. Exp. Med. 146, 857-868
59. Wendling D, Cedoz JP, Racadot E, Dumoulin G. 2007. Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine 74, 304-305
60. Wu HJ, et al. 2010. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 6, 815-827
61. Yago T, et al. 2007. IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res. Ther. 9, R96. http://arthritis-research.com/content/9/5 /R96.
62. Yin Z, et al. 1997. Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum. 40, 1788-1797
63. Yin Z, et al. 1999. The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta. J. Rheumatol. 38, 1058-1067
64. Zanelli E, Gonzalez-Gay MA, David CS. 1995. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol. Today 16, 274-278
65. Ziolkowska M, et al. 2000. High levels of IL-17 in rheumatoid arthritis patients, IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 164, 2832-2838.
66. Zizzo G, et al. 2011. Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. Clin. Immunol. 138, 107-116.
67. Zwerina K, et al. 2012. Anti IL-17A therapy inhibits bone loss in TNF-α mediated murine arthritis by modulation of the T-cell balance. Eur. J. Immunol. 42, 413-423.